Utama › Kanser Payudara › Colorado › Aurora
Kajian klinikal Kanser Payudara di Aurora, CO
27 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Aurora (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Mengambil pesertaFasa 1/2
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Mengambil pesertaFasa 2
- University of Colorado School of Medicine, Aurora
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Mengambil pesertaFasa 3
- University of Colorado Anschutz Medical Campus ( Site 0061), Aurora
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Mengambil pesertaFasa 3
- University of Colorado Anschutz Medical Campus, Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Mengambil pesertaFasa 3
- Research Site, Aurora
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Mengambil pesertaFasa 3
- Clinical Trial Site, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- University of Colorado Cancer Center, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Mengambil pesertaFasa 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- UCHealth University of Colorado Hospital, Aurora
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Mengambil pesertaFasa 2
- University Of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Mengambil pesertaFasa 2/3
- Local Institution - 0289, Aurora
E-Mindfulness Approaches for Living After Breast Cancer
Mengambil pesertaFasa 3
- UCHealth University of Colorado Hospital, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of Colorado Cancer Center, Aurora
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Mengambil pesertaFasa 1/2
- University of Colorado Anschutz Medical Campus ( Site 0057), Aurora
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Mengambil pesertaFasa 3
- Rocky Mountain Cancer Centers LLP, Aurora
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- University of Colorado Cancer Center, Aurora
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- UCHealth University of Colorado Hospital, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Rocky Mountain Cancer Centers-Aurora, Aurora
Improving Care for Rural Patients With Solid Tumors
Mengambil peserta
- University of Colorado Hospital, Aurora
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
Mengambil pesertaFasa 2
- University of Colorado Anschutz Medical Campus, Aurora
The Immune System's Response to Young Women's Breast Cancer
Mengambil pesertaKajian pemerhatian
- University of Colorado Denver, Aurora
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Mengambil pesertaKajian pemerhatian
- UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Aurora
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Mengambil pesertaKajian pemerhatian
- Rocky Mountain Cancer Centers, Aurora
- University of Colorado Cancer Center, Aurora
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Mengambil pesertaKajian pemerhatian
- University of Colorado Cancer Center, Aurora
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Mengambil pesertaFasa 3
- Rocky Mountain Cancer Centers - Aurora, Aurora
Kajian Kanser Payudara di bandar lain
- New York City, NY134 kajian
- Houston, TX126 kajian
- Boston, MA111 kajian
- Nashville, TN80 kajian
- Los Angeles, CA72 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Durham, NC63 kajian
- Queens, NY63 kajian
- Chicago, IL58 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Aurora
- Kanser (semua jenis)35 kajian
- Kanser Kolorektal32 kajian
- Kanser Paru-paru Bukan Sel Kecil30 kajian
- Kanser Metastatik25 kajian
- Kanser Ovari25 kajian
- Diabetes Jenis 123 kajian
- Obesiti21 kajian
- Kanser Paru-paru19 kajian
- Kanser Prostat19 kajian
- Kegagalan Jantung18 kajian
- Melanoma18 kajian
- Leukemia Mieloid Akut16 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.